Los puntos clave no están disponibles para este artículo en este momento.
This Viewpoint characterizes incidental radiographic findings from clinical trial–related imaging as an underrecognized potential harm of trial participation and proposes practices and standards to more systematically include them as a trial safety end point.
Oren et al. (Mon,) studied this question.